Skip to content

Effect of Restriction of Foods Containing Phosphorus Additives

Effect of Restriction of Foods Containing Phosphorus Additives on the Phosphatemia of Patients With End-stage Renal Disease.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01965379
Enrollment
140
Registered
2013-10-18
Start date
2012-01-31
Completion date
2014-06-30
Last updated
2015-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage Renal Disease, Hyperphosphatemia

Keywords

Dialysis, Phosphorus, Diet

Brief summary

Hyperphosphatemia is related to the increase in morbidity and mortality. There is greater risk for cardiovascular disease, atherosclerotic disease, secondary hyperparathyroidism, and bone disease . The serum phosphorus level can be controlled by a combination of factors, such as: reduction of ingestion, reduction of intestinal absorption with chelating agents and increase in elimination by dialysis. The purpose of this study is to evaluate the effect of dietary intervention consisting of the restriction of industrialized foods with phosphorus additives in chronic kidney disease patients treated with hemodialysis.

Detailed description

The consumption of foods which contain phosphorus by patients on hemodialysis should be monitored in order to reflect the current reality, due to the increase in ingestion of industrialized foods rich in phosphorus additives. Data from studies performed in the USA shows a reduction in phosphatemia with nutritional orientation to reduce foods containing additives from restaurants in the region of the study . In another study, also conducted in the USA, the researchers evaluated the phosphorus content and presence of additives in appetizers and side orders served at fast food restaurants in Cleveland. The results showed that of the appetizers, 52% were accepted by the traditional criteria for the renal diet (low content of sodium, potassium and organic or natural phosphorus), but only 16% were also free of phosphorus additives; of the side orders, 23% were accepted by the traditional criteria and 17% were exempt of phosphorus additives. Thus, only a small proportion of appetizers and side orders served at fast food restaurants were compatible with the renal diet. Considering that alimentary phosphorus has an important role in the control of phosphatemia, there is a lack of studies which evaluates the effect of foods containing phosphorus additives on phosphatemia and which, at the same time, evaluated the alimentary ingestion and the nutritional state of the chronic kidney disease patients treated with hemodialysis. Can the elimination of foods containing phosphorus additives and their substitution for foods without additives reduce phosphatemia without altering the nutritional state of hyperphosphatemic patients on hemodialysis?

Interventions

OTHERRestriction on food containing phosphorus additives

The substitution of foods containing phosphorus additives for others with the same nutritional value for each individual of the study.

OTHERStandard care

The control group mantained the usual renal diet oriented prior to the study with a booklet.

Sponsors

Faculdade de Ciências Médicas da Santa Casa de São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* males or female ≥ 18 years of age * Chronic kidney disease in stage 5, on hemodialysis for at least 6 months * Serum phosphorus (P) greater than 5.5 mg/dL persistent in 3 previous months * Preserved cognitive capacity and able to read and write * Signed informed written consent

Exclusion criteria

* Use of enteral or parenteral therapy * Presence of physical or cognitive limitation * Malabsorption diseases.

Design outcomes

Primary

MeasureTime frame
Change the serum levels of phosphorus to acceptable levels ( under 5.5 mg per dL)90 days

Secondary

MeasureTime frame
Protein intake at baseline and final.90 days
Energy intake at baseline and at the final.90 days
Triceps skinfold at baseline and final.90 days
Body mass index at baseline and final90 days
Arm muscle area at baseline and final90 days

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026